This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ucb Pharma, S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: **The Innovative Contributions of Joanna Rachel Thorne**
Introduction
Joanna Rachel Thorne is a distinguished inventor based in Slough, GB, known for her significant contributions to the field of pharmaceuticals. She holds one patent that showcases her innovation in developing thieno-pyridine derivatives, which have potential therapeutic applications in various medical conditions.
Latest Patents
Joanna's patent, titled "Thieno-pyridine derivatives as MEK inhibitors," encompasses a series of thieno[2,3-b]pyridine derivatives. These compounds are designed with a unique structure where a substituted anilino moiety of the 2-position is linked with a carbonyl group connected to a pyrrolidin-1-yl ring. This chemical configuration enables the derivatives to selectively inhibit human MEK (MAPKK) enzymes, offering benefits in treating inflammatory, autoimmune, cardiovascular, proliferative (including oncological), and nociceptive conditions.
Career Highlights
Throughout her career at UCB Pharma, S.A., Joanna has made remarkable strides in pharmaceutical innovation. Her work focuses on developing novel therapeutic agents that address critical healthcare challenges. Joanna's background and expertise contribute significantly to ongoing research aimed at advancing medical treatments, reflecting her dedication to improving patient outcomes.
Collaborations
Joanna collaborates with talented professionals, including colleagues like James Andrew Johnson and Daniel Christopher Brookings. Together, they foster an environment of innovation and creativity, pushing the boundaries of pharmaceutical research to develop effective treatment options.
Conclusion
In conclusion, Joanna Rachel Thorne stands out as a pioneering inventor in the pharmaceutical industry. Her patent on thieno-pyridine derivatives highlights her commitment to innovation and the potential to improve patient care through targeted therapies. As she continues her work at UCB Pharma, her contributions will undoubtedly shape the future of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile